The latest closing stock price for Cartesian Therapeutics as of November 20, 2024 is 16.94.
An investor who bought $1,000 worth of Cartesian Therapeutics stock at the IPO in 2016 would have $-960 today, roughly -1 times their original investment - a -33.06% compound annual growth rate over 8 years.
The all-time high Cartesian Therapeutics stock closing price was 789.90 on November 25, 2016.
The Cartesian Therapeutics 52-week high stock price is 42.64, which is 151.7% above the current share price.
The Cartesian Therapeutics 52-week low stock price is 11.66, which is 31.2% below the current share price.
The average Cartesian Therapeutics stock price for the last 52 weeks is 20.75.
An investor who bought $1,000 worth of Cartesian Therapeutics stock at the IPO in 2016 would have $-960 today, roughly -1 times their original investment - a -33.06% compound annual growth rate over 8 years.
The all-time high Cartesian Therapeutics stock closing price was 789.90 on November 25, 2016.
The Cartesian Therapeutics 52-week high stock price is 42.64, which is 151.7% above the current share price.
The Cartesian Therapeutics 52-week low stock price is 11.66, which is 31.2% below the current share price.
The average Cartesian Therapeutics stock price for the last 52 weeks is 20.75.